510(k) K982245
K982245 is an FDA 510(k) premarket notification submitted by Biosite Incorporated for the device "TRIAGE,PARASITE PANEL, TRIAGE CRYPTOSPORIDIUM AND ENTAMOEBA HISTOLYTICA, TRIAGE CRYPTOSPORIDIUM AND GIARDIA LAMBLIA". The FDA issued a decision of Substantially Equivalent on October 6, 1998. The device falls under product code MHI (Giardia Spp.), a Class II device regulated under 21 CFR 866.3220. Biosite Incorporated has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- October 6, 1998
- Date Received
- June 26, 1998
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Giardia Spp.
- Device Class
- Class II
- Regulation Number
- 866.3220
- Review Panel
- MI
- Submission Type